Acral and mucosal melanoma are rare subtypes which are refractory to standard treatment. This session will explore new target and treatment options for these rare subtypes. The second half of the session will detail the expansion in use of Mohs surgery for the treatment of melanoma in situ and very early stage melanoma.
